In melanoma, BRAF mutation is the most frequent alteration (50% of melanoma tumors) leading to abnormal activation of the RAS/RAF/MEK/ERK signaling pathway [1, 2, 3]. The gene discussed is MAP2K7; the disease is melanoma.